| The value of pyrans as anticancer scaffolds in medicinal chemistry D Kumar, P Sharma, H Singh, K Nepali, GK Gupta, SK Jain, F Ntie-Kang RSC advances 7 (59), 36977-36999, 2017 | 220 | 2017 |
| A Comprehensive Review of NHeterocycles as Cytotoxic Agents DKSK Jain Curr Med Chem. 23, 2016 | 112 | 2016 |
| Structure-activity-relationship and mechanistic insights for anti-HIV natural products R Kaur, P Sharma, GK Gupta, F Ntie-Kang, D Kumar Molecules 25 (9), 2070, 2020 | 73 | 2020 |
| Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors S Sharma, K Sharma, R Ojha, D Kumar, G Singh, K Nepali, PMS Bedi Bioorganic & medicinal chemistry letters 24 (2), 495-500, 2014 | 58 | 2014 |
| Anticancer Hybrids-A Patent Survey. KLD K Nepali, S Sharma, D Kumar, A Budhiraja Recent patents on anti-cancer drug discovery 9 (3), 303-339 (37), 2014 | 43 | 2014 |
| 4,6‐Diaryl/heteroarylpyrimidin‐2(1H)‐ones as a New Class of Xanthine Oxidase Inhibitors S Shukla, D Kumar, R Ojha, MK Gupta, K Nepali, PMS Bedi Archiv der pharmazie 347 (7), 486-495, 2014 | 38 | 2014 |
| 2, 4-Diarylpyrano [3, 2-c] chromen-5 (4H)-ones as antiproliferative agents: Design, synthesis and biological evaluation D Kumar, F Malik, PMS Bedi, S Jain Chemical and Pharmaceutical Bulletin 64 (5), 399-409, 2016 | 27 | 2016 |
| Bergenin-a biologically active scaffold: Nanotechnological perspectives R Madaan, RK Singla, S Kumar, AK Dubey, D Kumar, P Sharma, R Bala, ... Current Topics in Medicinal Chemistry 22 (2), 132-149, 2022 | 25 | 2022 |
| Treatment of tuberculosis by natural drugs: A review T Kaur, P Sharma, GK Gupta, F Ntie-Kang, D Kumar Plant Arch 19 (2), 2168-2176, 2019 | 23 | 2019 |
| Natural product-based studies for the management of castration-resistant prostate cancer: Computational to clinical studies RK Singla, P Sharma, AK Dubey, R Gundamaraju, D Kumar, S Kumar, ... Frontiers in Pharmacology 12, 732266, 2021 | 21 | 2021 |
| Naphthoflavones as antiproliferative agents: design, synthesis and biological evaluation D Kumar, O Singh, K Nepali, PMS Bedi, A Qayum, S Singh, S K Jain Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 20 | 2016 |
| 4-aryl/heteroaryl-4H-fused pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation D Kumar, G Singh, P Sharma, A Qayum, G Mahajan, MJ Mintoo, SK Singh, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 18 | 2018 |
| 4, 6-diaryl pyrimidones as constrained chalcone analogues: Design, synthesis and evaluation as antiproliferative agents D Kumar, K Nepali, PMS Bedi, S Kumar, F Malik, S Jain Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 18 | 2015 |
| phytochemistry and medicinal attributes of A. scholaris: A review P Sharma, R Sharma, HS Rao, D Kumar International Journal of Pharmaceutical Sciences and Research 7 (2), 505, 2016 | 17 | 2016 |
| Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2 (1H)-one against Ehrlich ascites carcinoma and sarcoma-180 D Kumar, P Sharma, K Nepali, G Mahajan, MJ Mintoo, A Singh, G Singh, ... Heliyon 4 (6), 2018 | 16 | 2018 |
| Assessment of antimicrobial potential and phytochemical profiling of ethnomedicinal plant Bergenia ciliata (Haw.) Sternb. in western Himalaya R Verma, A Tapwal, D Kumar, S Puri The Journal of Microbiology, Biotechnology and Food Sciences 9 (1), 15, 2019 | 15 | 2019 |
| Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives MS Hussain, E Moglad, M Afzal, G Gupta, WH Almalki, I Kazmi, SI Alzarea, ... Pathology-Research and Practice 258, 155303, 2024 | 12 | 2024 |
| The role of nanomaterials in enhancing natural product translational potential and modulating endoplasmic reticulum stress in the treatment of ovarian cancer RK Singla, P Sharma, D Kumar, RK Gautam, R Goyal, C Tsagkaris, ... Frontiers in Pharmacology 13, 987088, 2022 | 11 | 2022 |
| In search of therapeutic candidates for HIV/AIDS: rational approaches, design strategies, structure–activity relationship and mechanistic insights D Kumar, P Sharma, R Kaur, MMM Lobe, GK Gupta, F Ntie-Kang RSC advances 11 (29), 17936-17964, 2021 | 11 | 2021 |
| Overview of inorganic nanoparticles: An expanding horizon in tumor therapeutics L Kumar, S Verma, P Utreja, D Kumar Recent Patents on Anti-Cancer Drug Discovery 18 (3), 343-363, 2023 | 8 | 2023 |
Pooja SharmaPunjabi University, Patiala, Punjab, India; Khalsa College of Pharmacy Amritsar.Verified email at pbi.ac.in